Text Size
1040 studies found for:    multiple sclerosis.

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
multiple sclerosis. (1040 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Withdrawn Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.
Condition: Multiple Sclerosis
Interventions: Biological: Live Hookworm Larvae;   Other: Histamine
2 Withdrawn A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: A4I Antagonist
3 Completed
Has Results 		A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
4 Completed A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: glatiramer acetate 20 mg;   Drug: glatiramer acetate 20 mg, with mitoxantrone
5 Completed
Has Results 		Duloxetine for Multiple Sclerosis Pain
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine Hydrochloride (HCI);   Drug: Placebo
6 Completed Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri
7 Unknown † The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
8 Recruiting Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: BAF312;   Drug: Placebo
9 Terminated Motor Training and White Matter in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Device: tDCS;   Behavioral: Bimanual Training
10 Terminated Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: repository corticotropin injection;   Drug: Saline
11 Recruiting Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
Conditions: Relapsing Remitting MS;   Secondary Progressive MS;   Primary Progressive MS
Interventions: Dietary Supplement: Caprylic Triglyceride;   Dietary Supplement: Placebo
12 Completed Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
Condition: Detrusor Muscle Hyperactivity
Interventions: Drug: Botulinum type A toxin (Dysport®);   Drug: Placebo
13 Unknown † Multiple Sclerosis Rehabilitation Study
Condition: Multiple Sclerosis
Interventions: Behavioral: Physiotherapy;   Behavioral: Occupational therapy;   Behavioral: Speech pathology
14 Terminated Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: GSK1223249;   Other: Saline placebo
15 Active, not recruiting A Prospective Pilot Study to Compare the Effectiveness of Prolonged Fasting and Low Glycemic Load Treatment in Respect to the Health Related Quality of Life in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Comparison of prolonged fasting and low glycemic load treatment on health related quality of life in multiple sclerosis.
16 Recruiting The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis
Conditions: Posttraumatic Stress Disorders;   Multiple Sclerosis
Interventions: Behavioral: EMDR;   Behavioral: Relaxation
17 Completed
Has Results 		Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod 0.5 mg;   Drug: Fingolimod 1.25 mg
18 Unknown † Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Mycophenolate Mofetil (CellCept)
19 Completed
Has Results 		12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: Rebif® New Formulation (RNF) using RebiSmartTM
20 Active, not recruiting Exploratory Study to Assess the Effect of Fampridine on Walking Ability and Balance in Patients With Multiple Sclerosis.
Condition: Multiple Sclerosis
Interventions: Drug: PR Fampridine;   Other: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years